Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery

Cornea

Volumn 27, Issue 10, 2008, Pages 1119-1121

  Díaz, Lilliam ^a   Villegas, Víctor M ^a   Emanuelli, Andrés ^b   Izquierdo, Natalio J ^b,c  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c NONE   (Puerto Rico)

Author keywords

Mitomycin C; Pterygium surgery; Puerto Rican

Indexed keywords

MITOMYCIN C; PREDNISONE ACETATE; QUINOLONE DERIVATIVE; MITOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONJUNCTIVA CYST; CONJUNCTIVA DISEASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PTERYGIUM; RECURRENT DISEASE; SCLERA DISEASE; SCLERAL DELLEN; DRUG EFFECT; MIDDLE AGED; PATHOPHYSIOLOGY; PEROPERATIVE CARE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MITOMYCIN; PROSPECTIVE STUDIES; PTERYGIUM; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 60749087738     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318180e4fb     Document Type: Article

References (24)

1. Zorab R, Straus H, Dondrea C, et al. Degenerative and aging processes of the conjunctiva, cornea, and sclera. In: External Diseases and Cornea: Basic and Clinical Course. Section 8. San Francisco, CA: AAO; 2006-2007:366.
2. Massaoutis P, Khemka S, Ayliffe W. Clinical outcome study of a modified surgical technique for pterygium excision. Can J Ophthalmol. 2006;41: 704-708.
3. Kleis W, Pico G. Thio-TEPA therapy to prevent postoperative pterygium occurrence and neovascularization. Am J Ophthalmol. 1973; 76:371-373.
4. Bozkir N, Yilmaz S, Maden A. Minimally invasive pterygium surgery: a new approach for prevention of recurrence. Eur J Ophthalmol. 2008;18: 27-31.
5. Wu WK, Wong VW, Chi SC, et al. Surgical management of double-head pterygium by using a novel technique: conjunctival rotational autograft combined with conjunctival autograft. Cornea. 2007;26:1056-1059.
6. Ang LP, Chua JL, Tan DT. Current concepts and techniques in pterygium treatment [review]. Curr Opin Ophthalmol. 2007;18:308-313.
7. Katircioglu YA, Altiparmak UE, Duman S. Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C. Orbit. 2007;26: 5-13.
8. Nakamura T, Inatomi T, Sekiyama E, et al. Novel clinical application of sterilized, freeze-dried amniotic membrane to treat patients with pterygium. Acta Ophthalmol Scand. 2006;84:401-405.
9. Koranyi G, Seregard S, Kopp ED. The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol Scand. 2005; 83:298-301.
10. Ashaye AO. Modified bare sclera method for the treatment of primary pterygium: a preliminary report. West Afr J Med. 2005;24:66-69.
11. Kammoun B, Kharrat W, Zovari K, et al. Pterygium: surgical treatment. J Fr Ophtalmol. 2001;24:823-828.
12. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99: 1647-1654.
13. Donnefeld ED, Perry RD, Fromer S, et al. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision. Ophthalmology. 2003; 110:1012-1016.
14. Rachmiel R, Leiba H, Levartovsky S. Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium. Br J Ophthalmol. 1995;79:233-236.
15. Carrasco MA, Rapuano CJ, Cohen EJ, et al. Scleral ulceration after preoperative injection of mitomycin C in the pterygium head. Arch Ophthalmol. 2002;120:1585-1586.
16. Singh G, Wilson MR, Foster CS. Long-term follow-up study of mitomycin eye drops as adjunctive treatment for pterygia and its comparison with conjunctival autograft transplantation. Cornea. 1990;9: 331-334.
17. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea. 1996;15:537-540.
18. Tsai YY, Lin JM, Shy JD. Acute scleral thinning after pterygium excision with intraoperative mitomycin C. Cornea. 2002;21:227-229.
19. Fujitani A, Hayasaka S, Shibuya Y, et al. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica. 1993;207:162-164.
20. MacKenzie FD, Hirst LW, Kynaston B, et al. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology. 1991;98: 1776-1780.
21. Abraham LM, Selva D, Casson R, et al. Mitomycin: clinical applications in ophthalmic practice. Drugs. 2006;66:321-340.
22. Kunitomo N, Mori S. Studies on pterygium. Part 4. A treatment of the pterygium by mitomycin C instillation. Acta Soc Ophthalmol Jpn. 1963; 67:601-607.
23. Raiskup F, Solomon A, Landau D, et al. Mitomycin C for pterygium: long term evaluation. Br J Ophthalmol. 2004;88:1425-1428.
24. Walkow T, Anders N, Wollensak J. Effect of local administration of mitomycin C on intraocular pressure. Klin Monatsbl Augenheilkd. 1996; 209:354-357.